netFormulary NHS
Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust
 Search
 Results

Looking for Alemtuzumab found 4 matches

Open monograph to display formulary status BNF Category
  Alemtuzumab Malignant disease and immunosuppression - Anti-lymphocyte monoclonal antibodies - 08.02.03
  Cytotoxic Drug Bendamustine Malignant disease and immunosuppression - Alkylating drugs - 08.01.01
  Rituximab Malignant disease and immunosuppression - Anti-lymphocyte monoclonal antibodies - 08.02.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA 312: Alemtuzumab for treating relapsing‑remitting multiple sclerosis (08.02.03)


 

netFormulary